Affordable Access

Antisense therapy of MAdCAM-1 for trinitrobenzenesulfonic acid-induced murine colitis.

Authors
Type
Published Article
Journal
Inflammatory bowel diseases
Publication Date
Volume
12
Issue
8
Pages
758–765
Identifiers
PMID: 16917232
Source
Medline
License
Unknown

Abstract

These data suggest that antisense suppression of MAdCAM-1 is of equivalent effectiveness to that of anti-MAdCAM-1 or anti-alpha4 integrin antibody in previous reports and could be a new therapy for IBD.

Statistics

Seen <100 times